In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cardion AG

www.cardion.de

Latest From Cardion AG

Trigen makes two appointments

Trigen (Germany), a drug development company developing biologics for use in antithrombotic therapy, has appointed Dr Ayad Abdul-Ahad chief executive officer and Dr Norbert Bender chief medical officer. Dr Abdul-Ahad joins from Biogen Idec, where he served as vice-president and head of international medical affairs; he has also worked at Berlex Laboratories, AstraZeneca, SmithKline Beecham and Serono. Dr Bender has more than 10 years' experience as a medical doctor and has more than 15 years' experience in pharmaceutical companies, having previously worked at Hoescht, BASF Pharma Knoll, Cardion and The Vaccines Company.

Germany Companies

Roche's Partners: Replacing, or Fuelling In-House R&D?

Partnering is a must for every drug firm these days. But Roche's reputation as a committed, yet hands-off development partner--forged in its relationship with Genentech--still sets it apart. Critics accuse the Swiss group of using partners to fill the gap in its own R&D; indeed, much of Roche's recent growth has come from others' drugs. Roche executives argue that you can't spot winners outside without a strong internal engine; that engine remains unproven. But point isn't whether Roche's own R&D is strong or weak. The point is, does it matter?
BioPharmaceutical Europe

Recent Dealmaking (9/2003)

Summarizing the month in European dealmaking.

Recent Dealmaking (10/2002)

Summarizing the month in European dealmaking.
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Cardiogene AG
  • Intracardia Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Cardion AG
  • Senior Management
  • Niels Ackermann, CFO
    Dr. Manfred Ruediger, CSO
    Dr. Juergen Parrisius, VP, Bus. Dev.
  • Contact Info
  • Cardion AG
    Phone: (49) 211 205650
    Max-Planck-Strasse 15a
    Erkrath, D-40699
    Germany
Advertisement
Advertisement
UsernamePublicRestriction

Register